Navigation Links
Novartis Reports Omalizumab Significantly Improved Chronic Idiopathic Urticaria Symptoms in Patients Who Failed Standard Therapy
Date:2/24/2013

antihistamine. For the primary endpoint, the omalizumab 75 mg dose group did not demonstrate statistical significance compared to placebo. However, omalizumab 150 mg and 300 mg dose groups met the pre-specified primary endpoint and all eight pre-specified secondary endpoints in the ASTERIA II trial, except for the 150 mg dose that did not show a significant difference from placebo in the proportion of angioedema-free days from Week 4 to Week 12 of therapy. Patient response, as measured by the median time to Minimally Important Difference (MID) in itch severity score,  a secondary endpoint, occurred at Week 1 (300 mg dose) and Week 2 (150 mg dose), compared to Week 4 in the placebo group.

The incidence and severity of adverse events (AEs) was similar across treatment groups. The most frequently reported treatment-emergent adverse events in patients taking omalizumab (>10% in any omalizumab treatment arm) in the study (including treatment period and follow-up period) were nasopharyngitis (nasal and throat infection or common cold), idiopathic urticaria (hives and itching, trigger unknown) and headache.  Five (6.3%) patients experienced serious adverse events (SAEs) in the omalizumab 300 mg dose group, compared to two (2.5%) in the placebo group. In the 150 mg and 75 mg dose groups, one patient experienced SAEs in each group (1.1% and 1.3%, respectively). No deaths were reported during this study.

About Omalizumab
Omalizumab is not indicated for CIU.

Omalizumab is a biologic therapy unique in targeting immunoglobulin E (IgE). Research is ongoing to understand the mechanism of action of omalizumab in CIU and to investigate its potential impact on the drivers of CIU. Omalizumab is approved for the treatment of moderate to severe allergic asthma under the brand-name Xolair® in more than 90 countries, including the US since 2003 and the EU since 2005. In the US, Xolair is indicated for appropriate people who are
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Novartis Pharma Logistics, Inc. voluntarily recalling in Jamaica select lots of certain over-the-counter products due to bottle closure defect
2. Novartis Pharma Logistics, Inc. voluntarily recalling in Trinidad & Tobago select lots of certain over-the-counter products due to bottle closure defect
3. Novartis Pharma Logistics, Inc. voluntarily recalling in Curacao select lots of certain over-the-counter products due to bottle closure defect
4. Novartis Pharma Logistics, Inc. voluntarily recalling in Aruba select lots of certain over-the-counter products due to bottle closure defect
5. Novartis Pharma Logistics, Inc. voluntarily recalling in Barbados select lots of certain over-the-counter products due to bottle closure defect
6. Continued Uptake of Novartis/Incytes Jakafi Will Be the Greatest Driver of Growth in the Myelofibrosis Therapy Market
7. Novartis highlights key data in patients with hematologic diseases and breast cancer with more than 140 abstracts at ASH and SABCS
8. Thesan Pharmaceuticals offentliggør første runde af venturefinansieringen ledt af Novo Ventures og Novartis Venture Funds i fællesskab
9. Thesan Pharmaceuticals annuncia un finanziamento di serie A co-gestito da Novo Ventures e Novartis Venture Funds
10. Thesan Pharmaceuticals gibt Serie-A-Finanzierung unter gemeinsamer Führung von Novo Ventures und Novartis Venture Funds bekannt
11. Thesan Pharmaceuticals Announces Series A Funding Co-Led By Novo Ventures And Novartis Venture Funds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds ... to its store . (Photo: ... of population, consumption upgrade and policy support, ... seen rapid development over the years, with total ... 2006 to 9.85 billion yuan in 2012. ...
(Date:1/15/2014)... Jan. 15, 2014  Research and Markets ( ... "Dental Consumables Market - Global Industry Analysis, ... 2018" report to their offering. ... Dental consumables are products which are used ... for tooth restoration and in treatment of associated ...
(Date:1/15/2014)... , Jan. 15, 2014 AARP Foundation today ... to support older adults suffering from the severe cold ... and its members are committed to helping those in ... and AARP Foundation will match dollar-for-dollar contributions up to ... The matching program will be administered through AARP Foundation. ...
Breaking Medicine Technology:Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3
... , , , COLUMBIA, S.C. ... home pilot project that could become a model for South Carolina ... also attracting the attention of S.C. physicians not involved in the ... to managing their health care costs. , , ...
... , ANN ARBOR, Mich., July 24 Terumo ... Phase II Clinical Trial for the Anaconda(TM) AAA (Abdominal Aortic ... system is manufactured by Scotland-based Terumo subsidiary Vascutek Ltd. ... at Arizona Heart Hospital by the principal investigator, Julio Rodriguez-Lopez, ...
Cached Medicine Technology:S.C. Medical Home Pilot for Diabetes Enrolls 1,110 2S.C. Medical Home Pilot for Diabetes Enrolls 1,110 3Terumo Cardiovascular Systems Initiates U.S. Clinical Trial for Anaconda(TM) AAA Stent Graft System 2
(Date:4/14/2014)... Porter Graham Child Development Institute have released their ... to prepare four-year-olds for success in kindergarten. According ... show significant gains across all areas of learning. ... greater rate during their participation in NC Pre-K ... scientist Ellen Peisner-Feinberg, who leads the FPG team ...
(Date:4/14/2014)... children with uncomplicated acute appendicitis is a reasonable alternative ... missed school days, according to a pilot study. The ... and published online April 12 in the Journal ... first prospective study on nonoperative management of acute appendicitis ... Researchers enrolled 77 patients age 7 to 17 who ...
(Date:4/14/2014)... shows that domestic abuse is closely linked to ... stress disorder (PTSD), in mothers. The research also ... with specific mental health problems. The work was ... Simon Fraser University and the University of British ... how intimate partner abuse physical, psychological and ...
(Date:4/13/2014)... program for adolescent girls in Kenyan slums sharply ... who live in an environment where women have ... new study shows. , The findings, by researchers ... Packard Children,s Hospital Stanford and the nongovernmental organization ... in combating an appallingly common hazard among girls ...
(Date:4/11/2014)... a severe disease for which there is still no ... what happens in the brain of a schizophrenic person, ... proteins in the brains of rats that have been ... new and better medicines. , Seven per cent of ... have tried for centuries to understand the disease, they ...
Breaking Medicine News(10 mins):Health News:Study gives high marks to NC Pre-K program 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Study links domestic abuse to mental health problems in new mothers 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4Health News:Protein researches closing in on the mystery of schizophrenia 2Health News:Protein researches closing in on the mystery of schizophrenia 3
... that one in three early-stage breast cancer patients who ... they did not fully understand their discussions with physicians ... About one in four experienced distress when receiving their ... a peer-reviewed journal of the American Cancer Society, the ...
... Scientists at the Stanford University School of Medicine have ... device to virtually separate a whole-blood sample into its different ... any one of those cell types. In a study ... , the scientists reported that they had successfully used the ...
... that much harder to eliminate, scientists say , SUNDAY, March ... the AIDS virus in the blood to zero, but HIV ... their pills. Now, research is giving scientists new insight into ... powers of medicine. , In a new study, researchers ...
... ... Medicine residents in hypertension therapy and sleep disorders will receive international recognition at the ... ... the work of two St. Elizabeth Internal Medicine residents in hypertension therapy and sleep ...
... ... certification. Their revolutionary line of quick couplings and plastic fittings are all designed, ... ... -- Kent Systems received their Made in the USA Brand certification. Their revolutionary ...
... The Pediatric Cancer ... Annual “Reaching for the Cure” 10K Run, 5K Run/Walk, and 1K Kids’ Fun Run ... Irvine, CA (PRWEB) March 7, ... “Reaching for the Cure” Half Marathon | 10K 5K Run | 5K Walk | ...
Cached Medicine News:Health News:Improvements needed in genomic test result discussions 2Health News:Mathematical innovation turns blood draw into information gold mine in Stanford study 2Health News:Mathematical innovation turns blood draw into information gold mine in Stanford study 3Health News:Mathematical innovation turns blood draw into information gold mine in Stanford study 4Health News:HIV Hides Out in Bone Marrow Cells 2Health News:St. Elizabeth Medical Residents to Present Research at International Meeting, 2Health News:Kent Systems Received Made in the USA Brand Certification 2Health News:Sponsors for the 2010 Pediatric Cancer Research Foundation “Reaching for the Cure” Annual Cinco de Mayo Run/Walk Fundraising Event 2Health News:Sponsors for the 2010 Pediatric Cancer Research Foundation “Reaching for the Cure” Annual Cinco de Mayo Run/Walk Fundraising Event 3
The GE e-Speed™scanner, the worlds fastest computed tomography (CT) imaging platform, delivers a new advanced tool for physicians to see and diagnose heart disease....
...
Angled 45 Degrees to Right, 9.5mm blade, gently curved .5x .25mm blunt tips; Lower blade is 0.5mm longer; 14mm from mid screw to tip; (Available in left and right;) overall length 120mm; Stainless ...
16mm Slightly Curved sharp Tips; overall length 120mm; Stainless Steel...
Medicine Products: